(±) Pestalactone D and pestapyrone F, two new isocoumarins from an endolichenic Pestalotiopsis rhododendri.


Journal

The Journal of antibiotics
ISSN: 1881-1469
Titre abrégé: J Antibiot (Tokyo)
Pays: England
ID NLM: 0151115

Informations de publication

Date de publication:
11 2023
Historique:
received: 31 05 2023
accepted: 27 07 2023
revised: 17 07 2023
medline: 30 10 2023
pubmed: 24 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

Three isocoumarins, including two new compounds, (±) pestalactone D (1) and pestapyrone F (2), as well as one known compound, pestapyrone D (3), were isolated from the culture of the endolichenic Pestalotiopsis rhododendri LF-19-12. The planar structures of all compounds were elucidated by NMR and MS spectra. And the absolute configurations of 1 were confirmed by single crystal X-ray diffraction analysis, indicative of it as a racemate of 4S/12S and 4R/12R enantiomers. Compound 1 exhibited weak anti-coronaviral activity against human coronavirus HCoV-229E with an EC

Identifiants

pubmed: 37612463
doi: 10.1038/s41429-023-00646-7
pii: 10.1038/s41429-023-00646-7
doi:

Substances chimiques

Isocoumarins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

678-681

Informations de copyright

© 2023. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

Références

Singh BN, Upreti DK, Gupta VK, Dai XF, Jiang Y. Endolichenic fungi: a hidden reservoir of next generation biopharmaceuticals. Trends Biotechnol. 2017;35:808–13.
doi: 10.1016/j.tibtech.2017.03.003 pubmed: 28363407
Tripathi M, Joshi Y. Endolichenic fungi: a promising source for novel bioactive compounds. In: Tripathi M, Joshi Y, editors. Endolichenic fungi: present and future trends. Singapore: Springer Singapore; 2019. p. 69–118.
Kellogg JJ, Raja HA. Endolichenic fungi: a new source of rich bioactive secondary metabolites on the horizon. Phytochem Rev. 2016;16:271–93.
doi: 10.1007/s11101-016-9473-1
Zheng QC, Kong MZ, Zhao Q, Chen GD, Tian HY, et al. Chaetoglobosin Y, a new cytochalasan from Chaetomium globosum. Fitoterapia. 2014;93:126–31.
doi: 10.1016/j.fitote.2013.12.022 pubmed: 24418656
Dou Y, Wang X, Jiang D, Wang H, Jiao Y, et al. Metabolites from Aspergillus versicolor, an endolichenic fungus from the lichen Lobaria retigera. Drug Discov Ther. 2014;8:84–8.
doi: 10.5582/ddt.8.84 pubmed: 24815583
Wipf P, Halter RJ. Chemistry and biology of wortmannin. Org Biomol Chem. 2005;3:2053–61.
doi: 10.1039/b504418a pubmed: 15917886
Wu W, Dai H, Bao L, Ren B, Lu J, et al. Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp. J Nat Prod. 2011;74:1303–8.
doi: 10.1021/np100909y pubmed: 21428374
Wethalawe AN, Alwis YV, Udukala DN, Paranagama PA. Antimicrobial compounds isolated from endolichenic fungi: a review. Molecules. 2021;26:3901.
doi: 10.3390/molecules26133901 pubmed: 34202392 pmcid: 8271976
Luo M, Chang S, Li Y, Xi X, Chen M, et al. Molecular networking-based screening led to the discovery of a cyclic heptadepsipeptide from an endolichenic Xylaria sp. J Nat Prod. 2022;85:972–79.
doi: 10.1021/acs.jnatprod.1c01108 pubmed: 35385664
Luo M, Wang M, Chang S, He N, Shan G, et al. Halogenase-targeted genome mining leads to the discovery of (+/−) pestalachlorides A1a, A2a, and their atropisomers. Antibiotics (Basel). 2022;11:1304.
doi: 10.3390/antibiotics11101304 pubmed: 36289962
Song RY, Wang XB, Yin GP, Liu RH, Kong LY, et al. Isocoumarin derivatives from the endophytic fungus, Pestalotiopsis sp. Fitoterapia. 2017;122:115–18.
doi: 10.1016/j.fitote.2017.08.012 pubmed: 28842359
Cai Y, Rao L, Zou Y. Genome mining discovery of a C(4)-alkylated dihydroisocoumarin pathway in fungi. Org Lett. 2021;23:2337–41.
doi: 10.1021/acs.orglett.1c00458 pubmed: 33688736
Capon RJ. Extracting value: mechanistic insights into the formation of natural product artifacts – case studies in marine natural products. Nat Prod Rep. 2020;37:55–79.
doi: 10.1039/C9NP00013E pubmed: 31046051

Auteurs

Mengyuan Wang (M)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Mengna Luo (M)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Xiaotian Ding (X)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Shanshan Chang (S)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Ning He (N)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Bin Hong (B)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China.

Yunying Xie (Y)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No.1, Beijing, 100050, China. xieyy@imb.pumc.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH